|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Lenalidomideinduces long-lasting responses in elderly patients with chronic lymphoeyticleukemia显示文摘 | STRATI P KEATING MJ WIERDA WG | 2013 | Blood2013，122，5： | 1 |
| 2 | Fludarabine potentiates metabolism of cytarabine in patients with acute myelogenous leukemia during therapy显示文摘 | Gandhi V Estey E Keating MJ | 1993 | J Clin Oncol1993，11，1： | 1 |
| 3 | Campath-1H treatment of T-cell prolymphocytic leukemia in patients for whom at least one prior chemotherapy regimen has failed显示文摘 | Keating MJ Cazin B Coutr6 S | 2002 | J Clin Oncol2002，20，1： | 1 |
| 4 | Richter syndrome biology,incidence and therapeutic strategies显示文摘 | Tsimberiodu AM Keating MJ | 2005 | Cancer2005，103，2： | 1 |
| 5 | Treatment of advanced stages of Philadelphia chromosome-positive chronic myelogenous leukemia with interferon-alpha and low-dose cytarabine显示文摘 | Kantarjian HM Keating MJ Estey EH | 1992 | J Clin Oncol1992，10，5： | 1 |
| 6 | The clinical significance of tumor necrosis-alpha plasma level in patients having chronic lymphocytic leukemia显示文摘 | Keating MJ Manshouri T | 2002 | Blood2002，100，： | 1 |
| 7 | Low-dose alemtu-zumab (Campath) in myeloablative allogeneic stem cell transplantation for CD52-positive malignancies:decreased incidence of acute graft-versus-host-disease with unique pharmacokinetics显示文摘 | Khouri IF Keating MJ Saliba RM | 2004 | Bone Marrow Transplant2004，33，8： | 1 |
| 8 | A polymorphism in the tumo-meerosis factor-alpha gene promoter region may predispose to a poor-prognosis in COPD显示文摘 | Keatings VM Cave SJ Henry MJ | 2000 | Chest2000，118，4： | 1 |
| 9 | Long-term follow-up of patients with CLL treated with allogeneic hematopoietic transplantation显示文摘 | Khouri IF Keating MJ Saliba RM | 2002 | Cytotherapy2002，4，3： | 1 |
| 10 | Fludarabine potentiates metabolism of cytarabine in patients with acute myelogenous leukemia during therapy显示文摘 | Gandhi V Estey E Keating MJ | 1993 | J Clin Oncol1993，11，1： | 1 |
| 11 | Gossypol, a BH3 mimetic,induces apoptosis in chronic lymphocytic leukemia cells显示文摘 | Balakrishnan K Wierda WG Keating MJ | 2008 | Blood2008，112，5： | 1 |
| 12 | Richter syndrome:biology,incidence,and therapeutic strategies显示文摘 | Tsimberidou AM Keating MJ | 2005 | Cancer2005，103，2： | 1 |
| 13 | Early results of a chemoimmunotherapy regimen of fludarabine,cyclophosphamide,and rituximab as initial therapy for chronic lymphocytic leukesmia显示文摘 | Keating MJ O Brien S Albitar M | | 0，，： | 1 |
| 14 | Comparative outcomes of total joint arthroplasty显示文摘 | Ritter MA Albohm MJ Keating EM | 1995 | J Arthroplasty1995，10，： | 1 |
| 15 | Richter syndrome: biology, incidence, and therapeutic strategies 显示文摘 | Tsimberidou AM Keating MJ | 2005 | Cancer2005，103，2： | 1 |
| 16 | Ofatumum-ab显示文摘 | KEATING MJ’DRITSELIS A YASOTHAN U | 2010 | Nat Rev Drug Discov2010，9，2： | 1 |
| 17 | Relative value of ZAP- 70,CD38, and immunoglobulin mutation status in predicting aggressive disease in chronic lymphocytic leukemia显示文摘 | Rassenti LZ Jain S Keating MJ | 2008 | Blood2008，112，5： | 1 |
| 18 | A phase I study of fludarabine,cytarabine,and oxaliplatin therapy in patients with relapsed or refractory acute myeloid leukemia显示文摘 | Tsimberidou AM Keating MJ Jabbour EJ | 2014 | Clin Lymphoma Myeloma Leuk2014，14，： | 1 |
| 19 | P-glyoopmtein-170 inhibition significantly reduces cortisol and ciclosperin effhix from human intestinal epithelial cell and T lymphocytes显示文摘 | Farrell RJ Menconi MJ Keates AC | 2002 | Aliment Pharmacel Ther2002，16，5： | 1 |
| 20 | Early results of a chemoimmunotherapy regimen of fludarabine,Cyclophosphamide,and rituximab as initial therapy for chronic lymphocytic leukemia显示文摘 | Keating MJ O'Brien S Albitar M | 2005 | J Clin Oncol2005，23，18： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员